A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 4, 2001, Pages 1171-1182

  Chao, K S Clifford ^a   Bosch, Walter R ^a   Mutic, Sasa ^a   Lewis, Jason S ^a   Dehdashti, Farrokh ^a   Mintun, Mark A ^a   Dempsey, James F ^a   Perez, Carlos A ^a   Purdy, James A ^a   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cu ATSM; Hypoxia; IMRT; PET

Indexed keywords

COPPER DIACETYLBIS(N4 METHYLTHIOSEMICARBAZONE) CU 60; TRACER; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HYPOXIA; IMAGING; OXYGEN ELECTRODE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOSENSITIVITY; TECHNIQUE; TECHNOLOGY; TUMOR RESISTANCE;

ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; ORGANOMETALLIC COMPOUNDS; PHANTOMS, IMAGING; THIOSEMICARBAZONES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035869722     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01433-4     Document Type: Article

References (50)

1. Cancer statistics, 1997
2. The histological structure of some human lung cancers and the possible implications for radiotherapy
3. The oxygen effect and reoxygenation
4. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
5. Oxygenation of head and neck cancer; changes during radiotherapy and impact on treatment outcome
6. Techniques to assess the oxygenation of human tumors
7. 2 cyrospectrophotometry in prediction of tumour resistance caused by hypoxia
8. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
9. 2 tension measurements
10. New nonnitroimidazole hypoxia imaging agents, Cu-62-dithiosemicarbazone complexes with low redox potential
11. 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor; A novel radiopharmaceutical for positron emission tomography imaging
12. Copper-62-ATSM; A new hypoxia imaging agent with high membrane permeability and low redox potential
13. Comparative studies of Cu-64-ATSM and C-11-Acetate in an acute myocardial infarction model; Ex vivo imaging of hypoxia in rats
14. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
15. Selective 60/64Cu-ATSM uptake in hypoxic tumors correlated with direct tissue oxygen measurement, PET imaging and electronic autoradiography
16. Tumor response and salivary function sparing in patients with oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy (IMRT) with/without chemotherapy; The Mallinckrodt Institute of Radiology initial results
17. Intensity-modulated radiotherapy (IMRT) yields superior therapeutic outcome over conventional techniques with or without chemotherapy in locally advanced nasopharyngeal carcinoma
18. 125I implantation
19. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck; Results of an analysis from the RTOG head and neck database
20. Clinically relevant optimization of 3D conformal treatments
21. Impact of improved local control on survival
22. Optimization by simulated annealing of three-dimensional treatment planning for radiation fields defined by a multileaf collimator
23. Optimization by simulated annealing of three-dimensional, conformal treatment planning for radiation fields defined by a multileaf collimator; II. Inclusion of two-dimensional modulation of the x-ray intensity
24. Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region; The AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel
25. Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients
26. Advances in three-dimensional treatment planning and conformal dose delivery
27. Potential clinical efficacy of intensity-modulated conformal therapy
28. Integrated 3D Conformal planning/multivane intensity modulating delivery system for radiotherapy
29. Intensity modulated radiation therapy in head and neck cancers; The Mallinckrodt experience
30. Modulated beam conformal therapy for head and neck tumors
31. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region
32. Stereotactic imaging quality assurance using an anthropomorphic phantom
33. High purity production and potential applications of copper-60 and copper-61
34. Technetium labelled agents for imaging tissue hypoxia in vivo
35. In vitro and in vivo evaluation of a Technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia
36. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
37. Measurement of hypoxia in human tumors by SPECT imaging of iodoazomycin arabinoside
38. 18F] fluoromisonidazole; A pretherapy study of 37 patients
39. Nitroimidazoles and imaging hypoxia
40. Heterogeneity of polarographic oxygen tension measurements in cervix cancer; An evaluation of within and between tumor variability, probe position, and track depth
41. Bioreductive therapies; An overview of drugs and their mechanisms of action
42. The hypoxic cell; A target for selective cancer therapy-Eighteenth Bruce F. Cain Memorial Award lecture
43. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors
44. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas; A Phase II study
45. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
46. Distant metastases after irradiation alone in carcinoma of the uterine cervix
47. Towards multidimensional radiotherapy (MD-CRT); Biological imaging and biological conformality
48. Managing geometric uncertainty in conformal intensity-modulated radiation therapy
49. Quality assurance of serial tomotherapy for head and neck patient treatments